通过使用PPAR-γ抗剂的NMYC抑制诱导MYCN增强的神经母细胞瘤分化
Yukako Nakao-Ise1, Takumi Narita1, Shingo Miyamoto1
1Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.
Journal of clinical biochemistry and nutrition
|November 16, 2023
概括
PPAR-γ 抗剂通过促进细胞分化和亡来抑制神经母细胞瘤的生长. 这项研究表明了治疗儿童神经母细胞瘤的潜在新疗法策略.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症生物学 癌症生物学
- 分子治疗学分子治疗学
背景情况:
- 神经母细胞瘤是常见的儿科脑外固体瘤,具有神经元分化.
- 过氧体增殖器激活受体 (PPAR) -γ 具有神经保护性和抗瘤性质.
研究的目的:
- 调查PPAR-γ激动剂和抗剂在恶性神经母细胞瘤中的作用.
- 探索PPAR-γ调制在神经母细胞瘤治疗中的治疗潜力.
主要方法:
- 使用MYCN放大神经母细胞瘤CHP212细胞系进行体外研究.
- 服用PPAR-γ抗剂GW9662并评估对细胞生长,形态,分化标记 (TUBB3),细胞周期,细胞亡和基因表达 (NMYC,BCL2,BRD4) 的影响.
- 进行了体内研究,以评估瘤生长抑制和细胞分化.
主要成果:
- PPAR-γ抗剂GW9662剂量依赖地抑制了神经母细胞瘤细胞的生长.
- 对抗剂治疗诱导了神经元分化 (增加TUBB3),G1阶段停止和亡.
- 观察到NMYC,BCL2和BRD4的表达显著下降.
- 在体内研究证实了瘤生长抑制和细胞分化.
结论:
- PPAR-γ抗剂治疗促进神经母细胞细胞分化和亡,导致瘤生长抑制.
- 通过PPAR-γ对抗剂抑制BRD4,NMYC和BCL2是一个关键机制.
- PPAR-γ抗体代表了神经母细胞瘤的一个有前途的治疗和预防选择.
相关概念视频
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


